Recent Updates
Recently added Catalysts
NKTR Positive Sentiment

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024, after the close of U....

Thursday, October 31, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nektar Therapeutics will announce its financial results for Q3 2024 on November 7, 2024, after the close of U.S. markets. The announcement will be followed by a conference call hosted by CEO Howard Robin to review the results. Investors can access the press release, the conference call, and the subsequent replay details through the company's website. This event demonstrates Nektar's commitment to keeping stakeholders informed about its financial performance.
Price reaction · baseline $18.75 (2024-10-30 close) · hit after-hours · 2 other NKTR headline(s) in the window, move may be shared
day 0 close · peak
-4.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Nektar is preparing to announce its financial results, indicating continued operations.
  • A conference call will be hosted by the CEO to discuss the results, promoting transparency and investor communication.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+186%
120-day peak, hindsight
Typical move
10.2%
average across 4 past catalysts
Cash runway
~40 mo
Minimal dilution risk
Lead asset
Rezpegaldesleukin
Phase 3 · Moderate-to-Severe Atopic Dermatitis

Full Press Release Details

SAN FRANCISCO , Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after the close of U.S.-based financial markets. Howard Robin , President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time .
The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/ . The web broadcast of the conference call will be available for replay through December 7, 2024 .
To access the conference call, please pre-register at Nektar Earnings Call Registration . All registrants will receive dial-in information and a PIN allowing them to access the live call.

Frequently Asked Questions

When will Nektar Therapeutics release its Q3 2024 results?

Nektar Therapeutics will announce its Q3 2024 results on November 7, 2024.

What time is the Nektar earnings call scheduled?

The earnings call is scheduled for 5:00 p.m. Eastern Time.

How can I access the conference call?

Access the conference call by pre-registering at Nektar Earnings Call Registration.

When will the conference call replay be available?

The replay of the conference call will be available until December 7, 2024.

Who can I contact for investor inquiries at Nektar?

For investor inquiries, contact Vivian Wu at Nektar Therapeutics.

ShareAdd on Google
Tags: NKTR Viatris Investor Conferences Healthcare Nektar Therapeutics Q3 2024 financial results conference call Howard Robin
Last updated: Oct 31, 2024

Biotech snapshot

Cash runway
$1023M liquidity · $25M/mo burn
~40 mo
Minimal dilution risk
Lead asset
RezpegaldesleukinPhase 3
Moderate-to-Severe Atopic Dermatitis →

Catalyst track record

+186%
best trade around NKTR's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for NKTR.

See every catalyst's timing & PoA →